Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Climacteric ; 22(1): 51-54, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30572747

RESUMO

Hot flushes remain a debilitating aspect of menopause, disrupting daytime activities and sleep, and may last for years. Estrogen replacement is an effective treatment, but takes time to become maximally effective and is contraindicated in a significant proportion of women, most notably after breast cancer. Effective, non-hormonal therapies are therefore required. Recent years have seen substantial increases in understanding of the role of novel neuropeptides and tachykinins in hypothalamic function, particularly in the regulation of the reproductive axis through control of gonadotropin releasing hormone secretion, but with links to the control of vasomotor function. Neurokinin B, often co-expressed with kisspeptin in hypothalamic neurons, appears to be a key factor in the control of both systems. Several neurokinin B antagonists have been developed; data are emerging as to their effectiveness in the treatment of menopausal hot flushes. While data remain limited, these agents appear to have a remarkably fast onset of action, with the first 1 or 2 days of administration, and with a dramatic effect on both daytime flushes and night sleep disturbance. If safety and long-term function can be confirmed, these novel agents will be an important advance in therapy.


Assuntos
Gonadotropinas/metabolismo , Fogachos/tratamento farmacológico , Menopausa/efeitos dos fármacos , Neurocinina B/metabolismo , Receptores da Neurocinina-3/antagonistas & inibidores , Feminino , Hormônio Liberador de Gonadotropina/metabolismo , Humanos , Kisspeptinas/metabolismo , Neurocinina B/antagonistas & inibidores , Ensaios Clínicos Controlados Aleatórios como Assunto , Receptores da Neurocinina-3/metabolismo , Resultado do Tratamento
2.
Cell Signal ; 43: 71-84, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29277445

RESUMO

G protein-coupled receptors (GPCR) can participate in a number of signaling pathways, and this property led to the concept of biased GPCR agonism. Agonists, antagonists and allosteric modulators can bind to GPCRs in different ways, creating unique conformations that differentially modulate signaling through one or more G proteins. A unique neuromedin B (NMBR) GPCR-signaling platform controlling mammalian neuraminidase-1 (Neu1) and matrix metalloproteinase-9 (MMP9) crosstalk has been reported in the activation of the insulin receptor (IR) through the modification of the IR glycosylation. Here, we propose that there exists a biased GPCR agonism as small diffusible molecules in the activation of Neu1-mediated insulin receptor signaling. GPCR agonists bombesin, bradykinin, angiotensin I and angiotensin II significantly and dose-dependently induce Neu1 sialidase activity and IR activation in human IR-expressing rat hepatoma cell lines (HTC-IR), in the absence of insulin. Furthermore, the GPCR agonist-induced Neu1 sialidase activity could be specifically blocked by the NMBR inhibitor, BIM-23127. Protein expression analyses showed that these GPCR agonists significantly induced phosphorylation of IRß and insulin receptor substrate-1 (IRS1). Among these, angiotensin II was the most potent GPCR agonist capable of promoting IRß phosphorylation in HTC-IR cells. Interestingly, treatment with BIM-23127 and Neu1 inhibitor oseltamivir phosphate were able to block GPCR agonist-induced IR activation in HTC cells in vitro. Additionally, we found that angiotensin II receptor (type I) exists in a multimeric receptor complex with Neu1, IRß and NMBR in naïve (unstimulated) and stimulated HTC-IR cells with insulin, bradykinin, angiotensin I and angiotensin II. This complex suggests a molecular link regulating the interaction and signaling mechanism between these molecules on the cell surface. These findings uncover a biased GPCR agonist-induced IR transactivation signaling axis, mediated by Neu1 sialidase and the modification of insulin receptor glycosylation.


Assuntos
Metaloproteinase 9 da Matriz/metabolismo , Neuraminidase/metabolismo , Receptor de Insulina/genética , Receptores Acoplados a Proteínas G/agonistas , Transdução de Sinais , Ativação Transcricional/genética , Animais , Linhagem Celular , Humanos , Insulina/farmacologia , Neurocinina B/análogos & derivados , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Oseltamivir/farmacologia , Peptídeos Cíclicos/farmacologia , Fosforilação/efeitos dos fármacos , Subunidades Proteicas/metabolismo , Ratos , Receptores Acoplados a Proteínas G/metabolismo , Ativação Transcricional/efeitos dos fármacos
3.
Ann Endocrinol (Paris) ; 78 Suppl 1: S31-S40, 2017 Oct.
Artigo em Francês | MEDLINE | ID: mdl-29157487

RESUMO

The endocrine and exocrine functions of the gonads are controlled by the gonadotrope axis, whose master regulator is the hypothalamic decapeptide GnRH. The Kisspeptin/Neurokinin B (Kp/NkB) neuronendocrine system is the main physiologic regulator of GnRH neurons. The Kp/NkB system is currently considered the key mediator for the hypothalamic negative feedback exerted by sex steroids and prolactin, as well as by various metabolic signals. Intrinsic alterations or regulatory abnormalities of Kp/NkB system lead to various gonadotrope axis puberty and fertility dysfunctions. Molecular inactivations of Kp/NkB system actors are associated with some forms of congenital hypogonadotropic hypogonadism without anosmia. The Kp/NkB System is also involved in a few forms of precocious puberty. Finally, the Kp/NKB system is also implicated in gonadotrope axis alterations leading to functional hypothalamic amenorrhea or hyperprolactinemia. NkB is particularly and directly involved in vasomotor menopausal hot flushes mechanism. Various Kp/NkB agonist/antagonist compounds have been developed during the last ten years, and are currently being evaluated in humans. These molecules have potential applications not only in rare genetic diseases with Kp/NkB alterations, but also in various gonadotrope axis-related diseases or in vitro fertilization. The administration of NkB antagonists in menopausal women represents a real therapeutic advance because of their impressive effect in controlling vasomotor menopausal hot flushes.


Assuntos
Hormônio Liberador de Gonadotropina/análogos & derivados , Hormônio Liberador de Gonadotropina/uso terapêutico , Gônadas/fisiologia , Antagonistas de Hormônios/uso terapêutico , Sistema Hipotálamo-Hipofisário/fisiologia , Sistema Hipófise-Suprarrenal/fisiologia , Animais , Feminino , Gonadotrofos/metabolismo , Hormônio Liberador de Gonadotropina/agonistas , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Gônadas/efeitos dos fármacos , Gônadas/metabolismo , Humanos , Hipogonadismo/terapia , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/metabolismo , Kisspeptinas/agonistas , Kisspeptinas/antagonistas & inibidores , Kisspeptinas/metabolismo , Masculino , Menopausa/efeitos dos fármacos , Neurocinina B/agonistas , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Sistema Hipófise-Suprarrenal/metabolismo , Maturidade Sexual/efeitos dos fármacos , Maturidade Sexual/fisiologia
4.
Endocrinology ; 158(10): 3269-3280, 2017 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-28977601

RESUMO

Loss-of-function or inactivating mutations in the genes coding for kisspeptin and its receptor (KISS1R) or neurokinin B (NKB) and the NKB receptor (NK3R) in humans result in a delay in or the absence of puberty. However, precise mechanisms of kisspeptin and NKB signaling in the regulation of the pubertal increase in gonadotropin-releasing hormone (GnRH) release in primates are unknown. In this study, we conducted a series of experiments infusing agonists and antagonists of kisspeptin and NKB into the stalk-median eminence, where GnRH, kisspeptin, and NKB neuroterminal fibers are concentrated, and measuring GnRH release in prepubertal and pubertal female rhesus monkeys. Results indicate that (1) similar to those previously reported for GnRH stimulation by the KISS1R agonist (i.e., human kisspeptin-10), the NK3R agonist senktide stimulated GnRH release in a dose-responsive manner in both prepubertal and pubertal monkeys; (2) the senktide-induced GnRH release was blocked in the presence of the KISS1R antagonist peptide 234 in pubertal but not prepubertal monkeys; and (3) the kisspeptin-induced GnRH release was blocked in the presence of the NK3R antagonist SB222200 in the pubertal but not prepubertal monkeys. These results are interpreted to mean that although, in prepubertal female monkeys, kisspeptin and NKB signaling to GnRH release is independent, in pubertal female monkeys, a reciprocal signaling mechanism between kisspeptin and NKB neurons is established. We speculate that this cooperative mechanism by the kisspeptin and NKB network underlies the pubertal increase in GnRH release in female monkeys.


Assuntos
Hormônio Liberador de Gonadotropina/metabolismo , Kisspeptinas/fisiologia , Macaca mulatta/fisiologia , Neurocinina B/fisiologia , Maturidade Sexual/fisiologia , Transdução de Sinais/fisiologia , Animais , Feminino , Kisspeptinas/agonistas , Kisspeptinas/antagonistas & inibidores , Kisspeptinas/farmacologia , Eminência Mediana/efeitos dos fármacos , Neurocinina B/agonistas , Neurocinina B/antagonistas & inibidores , Neurônios/metabolismo , Fragmentos de Peptídeos/farmacologia , Quinolinas/farmacologia , Receptores Acoplados a Proteínas G/agonistas , Receptores Acoplados a Proteínas G/antagonistas & inibidores , Receptores de Kisspeptina-1 , Receptores da Neurocinina-3/agonistas , Transdução de Sinais/efeitos dos fármacos , Substância P/análogos & derivados , Substância P/farmacologia
5.
Reprod Domest Anim ; 52 Suppl 2: 354-358, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27859771

RESUMO

The intent of this contribution is to provide an update of the progress we have made towards developing a method/treatment to permanently sterilize cats. Our approach employs two complementary methodologies: RNA interference (RNAi) to silence genes involved in the central control of reproduction and a virus-based gene therapy system intended to deliver RNAi selectively to the hypothalamus (where these genes are expressed) via the systemic administration of modified viruses. We selected the hypothalamus because it contains neurons expressing Kiss1 and Tac3, two genes essential for reproduction and fertility. We chose the non-pathogenic adeno-associated virus (AAV) as a vector whose tropism could be modified to target the hypothalamus. The issues that must be overcome to utilize this vector as a delivery vehicle to induce sterility include modification of the wild-type AAV to target the hypothalamic region of the brain with a simultaneous reduction in targeting of peripheral tissues and non-hypothalamic brain regions, identification of RNAi targets that will effectively reduce the expression of Kiss1 and Tac3 without off-target effects, and determination if neutralizing antibodies to the AAV serotype of choice are present in cats. Successful resolution of these issues will pave the way for the development of a powerful tool to induce the permanent sterility in cats.


Assuntos
Gatos , Anticoncepção/veterinária , Dependovirus , Inativação Gênica , Vetores Genéticos , Hipotálamo , Animais , Anticoncepção/métodos , Expressão Gênica/efeitos dos fármacos , Engenharia Genética/métodos , Engenharia Genética/veterinária , Infertilidade/etiologia , Infertilidade/veterinária , Kisspeptinas/antagonistas & inibidores , Kisspeptinas/genética , Neurocinina B/antagonistas & inibidores , Neurocinina B/genética , Interferência de RNA
6.
Endocr Dev ; 30: 106-29, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26684214

RESUMO

Reproductive hormones play a role at all stages of life and affect most tissues of the body. Gonadotropin-releasing hormone (GnRH) synthesized in the hypothalamus stimulates the secretion of gonadotropins which in turn stimulate gonadal sex hormone production and gamete formation. This hypothalamic-pituitary-gonadal (HPG) axis has, therefore, been the target for the development of numerous drugs which regulate it at various points. These include sex steroid agonists and antagonists, inhibitors of sex steroid biosynthesis, and GnRH agonists and antagonists, which have found extensive applications in treating numerous conditions such as precocious puberty, delayed puberty, prostate cancer, benign prostatic hyperplasia, endometriosis, uterine fibroids and also in in vitro fertilization protocols. The novel neuroendocrine peptides, kisspeptin (KP) and neurokinin B (NKB), were recently discovered as upstream regulators of GnRH, and inactivating mutations of KP and NKB ligands or receptors result in a failure to progress through puberty. Agonists and antagonists of KP and NKB are being developed as more subtle modulators of the HPG axis. These new drugs offer additional and alternative therapeutic options in pediatric and adult hormone-dependent diseases.


Assuntos
Hormônios Esteroides Gonadais , Hormônio Liberador de Gonadotropina/agonistas , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Gônadas/metabolismo , Sistema Hipotálamo-Hipofisário/metabolismo , Kisspeptinas , Neurocinina B , Hormônios Esteroides Gonadais/agonistas , Hormônios Esteroides Gonadais/antagonistas & inibidores , Humanos , Kisspeptinas/agonistas , Kisspeptinas/antagonistas & inibidores , Neurocinina B/agonistas , Neurocinina B/antagonistas & inibidores
7.
ACS Chem Neurosci ; 4(10): 1371-81, 2013 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-23875773

RESUMO

Neurokinin B (NKB) is a member of the tachykinin family of neuropeptides that have neuroinflammatory, neuroimmunological, and neuroprotective functions. In a neuroprotective role, tachykinins can help protect cells against the neurotoxic processes observed in Alzheimer's disease. A change in copper homeostasis is a clear feature of Alzheimer's disease, and the dysregulation may be a contributory factor in toxicity. Copper has recently been shown to interact with neurokinin A and neuropeptide γ and can lead to generation of reactive oxygen species and peptide degradation, which suggests that copper may have a place in tachykinin function and potentially misfunction. To explore this, we have utilized a range of spectroscopic techniques to show that NKB, but not substance P, can bind Cu(II) in an unusual [Cu(II)(NKB)2] neutral complex that utilizes two N-terminal amine and two imidazole nitrogen ligands (from each molecule of NKB) and the binding substantially alters the structure of the peptide. Using 1321N1 astrocytoma cells, we show that copper can enter the cells and subsequently open plasma membrane calcium channels but when bound to neurokinin B copper ion uptake is inhibited. This data suggests a novel role for neurokinin B in protecting cells against copper-induced calcium changes and implicates the peptide in synaptic copper homeostasis.


Assuntos
Doença de Alzheimer/metabolismo , Astrocitoma/química , Astrocitoma/metabolismo , Cobre/química , Neurocinina B/química , Doença de Alzheimer/patologia , Doença de Alzheimer/prevenção & controle , Astrocitoma/patologia , Linhagem Celular Tumoral , Complexos de Coordenação/química , Complexos de Coordenação/metabolismo , Cobre/metabolismo , Humanos , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Peptídeos/química , Peptídeos/metabolismo , Ligação Proteica
8.
Am J Physiol Endocrinol Metab ; 303(10): E1252-63, 2012 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-23011064

RESUMO

Kisspeptins (Kp), products of the Kiss1 gene, have emerged as essential elements in the control of GnRH neurons and gonadotropic secretion. However, despite considerable progress in the field, to date limited attention has been paid to elucidate the potential interactions of Kp with other neurotransmitters known to centrally regulate the gonadotropic axis. We characterize herein the impact of manipulations of key aminoacidergic (glutamate and GABA), peptidergic (NKB, Dyn, and MCH), and gaseous [nitric oxide (NO)] neurotransmission on gonadotropin responses to Kp-10 in male rats. Blockade of ionotropic glutamate receptors (of the NMDA and non-NMDA type) variably decreased LH responses to Kp-10, whereas activation of both ionotropic and metabotropic receptors, which enhanced LH and FSH release per se, failed to further increase gonadotropin responses to Kp-10. In fact, coactivation of metabotropic receptors attenuated LH and FSH responses to Kp-10. Selective activation of GABA(A) receptors decreased Kp-induced gonadotropin secretion, whereas their blockade elicited robust LH and FSH bursts and protracted responses to Kp-10 when combined with GABA(B) receptor inhibition. Blockade of Dyn signaling (at κ-opioid receptors) enhanced LH responses to Kp-10, whereas activation of Dyn and NKB signaling modestly reduced Kp-induced LH and FSH release. Finally, MCH decreased basal LH secretion and modestly reduced FSH responses to Kp-10, whereas LH responses to Kp-10 were protracted after inhibition of NO synthesis. In summary, we present herein evidence for the putative roles of glutamate, GABA, Dyn, NKB, MCH, and NO in modulating gonadotropic responses to Kp in male rats. Our pharmacological data will help to characterize the central interactions and putative hierarchy of key neuroendocrine pathways involved in the control of the gonadotropic axis.


Assuntos
Hormônio Foliculoestimulante/metabolismo , Kisspeptinas/farmacologia , Hormônio Luteinizante/metabolismo , Transmissão Sináptica/efeitos dos fármacos , Animais , Dineínas/antagonistas & inibidores , Dineínas/metabolismo , Hormônio Foliculoestimulante/sangue , Ácido Glutâmico/metabolismo , Hormônios Hipotalâmicos/agonistas , Hormônios Hipotalâmicos/antagonistas & inibidores , Hormônios Hipotalâmicos/metabolismo , Hormônio Luteinizante/sangue , Masculino , Melaninas/agonistas , Melaninas/antagonistas & inibidores , Melaninas/metabolismo , Neurocinina B/agonistas , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico/biossíntese , Óxido Nítrico/metabolismo , Hormônios Hipofisários/agonistas , Hormônios Hipofisários/antagonistas & inibidores , Hormônios Hipofisários/metabolismo , Ratos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos , Ácido gama-Aminobutírico/metabolismo
9.
J Neurosci ; 32(25): 8686-95, 2012 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-22723708

RESUMO

Here we used an array-based differential screen to uncover the expression of the neuropeptide neuromedin B (NMB) in the trigeminal ganglia of mice. Double-labeling experiments reveal NMB is expressed in a subset of sensory neurons that colabel with calcitonin gene-related peptide and TRPV1 suggestive of a role for NMB in nociception. Indeed, administration of NMB antagonist greatly attenuates edema and nerve sensitization following stimulation of peripheral nerves with mustard oil, demonstrating that NMB contributes to neurogenic inflammation. Moreover, direct injection of NMB causes local swelling and nociceptive sensitization. Interestingly, we also find that the receptor for NMB is expressed in interneurons in the superficial layers of the dorsal horn. We used NMB-saporin to specifically eliminate NMBR-expressing neurons and determined they are required in responses to noxious heat, but not for reaction to mechanical and pruritic stimuli. Thus, NMB may be a neurotransmitter that is selectively involved in the perception of thermal stimuli.


Assuntos
Neurocinina B/análogos & derivados , Nociceptividade/fisiologia , Animais , Comportamento Animal/fisiologia , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Gânglios Espinais/metabolismo , Temperatura Alta , Imuno-Histoquímica , Hibridização In Situ , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Análise em Microsséries , Neurite (Inflamação)/patologia , Neurocinina B/antagonistas & inibidores , Neurocinina B/farmacologia , Neurocinina B/fisiologia , Neuropeptídeos/biossíntese , Medição da Dor/efeitos dos fármacos , Células do Corno Posterior/fisiologia , Receptores da Bombesina/biossíntese , Receptores da Bombesina/genética , Células Receptoras Sensoriais/metabolismo , Transdução de Sinais/fisiologia , Medula Espinal/fisiologia , Substância P/metabolismo
10.
J Pharmacol Exp Ther ; 337(3): 822-9, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21421741

RESUMO

Bombesin is a pruritogenic agent that causes intense itch-scratching activity in rodents. Bombesin has high affinity for the gastrin-releasing peptide (GRP) receptor (GRPr) and the neuromedin B (NMB) receptor (NMBr). The aim of this study was to investigate pharmacologically the ability of GRPr and NMBr to elicit scratching behavior in rats. The intracerebroventricular route was selected for drug delivery because the study focused on supraspinal sites of action. The magnitude and duration of scratching produced by the naturally occurring peptides GRP and NMB were characterized. Antagonists selective for GRPr [(d-Tpi6, Leu13Ψ(CH2-NH)-Leu14)Bombesin(6-14) (RC-3095)] and NMBr [(S)-α-methyl-α-[[[(4-nitrophenyl)amino]carbonyl]amino]-N-[[1-(2-pyridinyl)cyclohexyl]methyl]-1H-indole-3-propanamide (PD168368)] were used to define the role of GRPr and NMBr in the scratching response. After intracerebroventricular administration, GRP (0.03-0.3 nmol) and NMB (0.1-1 nmol) dose-dependently elicited marked scratching. There was a tolerance to scratching elicited by daily repeated administration of bombesin, GRP, or NMB. Presession administration of RC-3095 (0.1-1 nmol) and PD168368 (0.3-3 nmol) dose-dependently antagonized scratching elicited by GRP and NMB, respectively. More importantly, 1 nmol of RC-3095 failed to block NMB-elicited scratching, and 3 nmol of PD168368 failed to block GRP-elicited scratching. In addition, pretreatment with effective doses of RC-3095 or PD168368 alone or in combination did not block bombesin-elicited scratching. Through the use of the selective antagonists RC-3095 and PD168368, this study demonstrates that central GRPr and NMBr act independently to elicit scratching behavior and there is an additional, unidentified receptor mechanism underlying bombesin-elicited scratching.


Assuntos
Bombesina/farmacologia , Peptídeo Liberador de Gastrina/farmacologia , Neurocinina B/análogos & derivados , Neurotransmissores/farmacologia , Prurido/metabolismo , Receptores da Bombesina/fisiologia , Animais , Bombesina/análogos & derivados , Bombesina/antagonistas & inibidores , Relação Dose-Resposta a Droga , Peptídeo Liberador de Gastrina/antagonistas & inibidores , Indóis/farmacologia , Infusões Intraventriculares , Masculino , Neurocinina B/antagonistas & inibidores , Neurocinina B/farmacologia , Fragmentos de Peptídeos/farmacologia , Prurido/induzido quimicamente , Piridinas/farmacologia , Ratos , Ratos Wistar
11.
Eur J Pharmacol ; 586(1-3): 306-12, 2008 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-18353309

RESUMO

Neurokinins are known to induce neurogenic inflammation related to respiratory diseases, though there is little information on triple neurokinin receptor antagonists. The pharmacological properties of the novel triple neurokinin 1, 2 and 3 receptor antagonist [1-(2-[(2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl]ethyl)spiro[benzo[c]thiophene-1(3H),4'-piperidine]-(2S)-oxide hydrochloride] (CS-003) were evaluated in this study. The binding affinities of CS-003 were evaluated with human and guinea pig neurokinin receptors. As well, the in vivo antagonism of CS-003 against exogenous neurokinins and effects on capsaicin-induced and citric acid-induced responses were investigated in guinea pigs. CS-003 exhibited high affinities for human neurokinin 1, neurokinin 2 and neurokinin 3 receptors with Ki values (mean+/-S.E.M.) of 2.3+/-0.52, 0.54+/-0.11 and 0.74+/-0.17 nM, respectively, and for the guinea pig receptors with Ki values of 5.2+/-1.4, 0.47+/-0.075 and 0.71+/-0.27 nM, respectively. Competitive antagonism was indicated in a Schild analysis of substance P-, neurokinin A- and neurokinin B-induced inositol phosphate formation with pA2 values of 8.7, 9.4 and 9.5, respectively. CS-003 inhibited substance P-induced tracheal vascular hyperpermeability, neurokinin A- and neurokinin B-induced bronchoconstriction with ID50 values of 0.13, 0.040 and 0.063 mg/kg (i.v.), respectively. CS-003 also inhibited capsaicin-induced bronchoconstriction (ID50: 0.27 mg/kg, i.v.), which is caused by endogenous neurokinins. CS-003 significantly inhibited citric acid-induced coughs and the effect was greater than those of other selective neurokinin receptor antagonists. CS-003 is a potent antagonist of triple neurokinin receptors and may achieve the best therapeutic efficacy on respiratory diseases associated with neurokinins compared to selective neurokinin receptor antagonists.


Assuntos
Óxidos S-Cíclicos/farmacologia , Morfolinas/farmacologia , Neurocinina A/antagonistas & inibidores , Neurocinina A/farmacologia , Neurocinina B/antagonistas & inibidores , Neurocinina B/farmacologia , Antagonistas dos Receptores de Neurocinina-1 , Receptores da Neurocinina-2/antagonistas & inibidores , Receptores da Neurocinina-3/antagonistas & inibidores , Animais , Brônquios/efeitos dos fármacos , Células COS , Permeabilidade Capilar/efeitos dos fármacos , Capsaicina/antagonistas & inibidores , Capsaicina/farmacologia , Chlorocebus aethiops , Ácido Cítrico , Tosse/induzido quimicamente , Tosse/prevenção & controle , Dipeptídeos/farmacologia , Relação Dose-Resposta a Droga , Cobaias , Humanos , Técnicas In Vitro , Indóis/farmacologia , Fosfatos de Inositol/biossíntese , Masculino , Dados de Sequência Molecular , Receptores da Neurocinina-1/metabolismo , Receptores da Neurocinina-2/metabolismo , Receptores da Neurocinina-3/metabolismo , Substância P/farmacologia , Traqueia/irrigação sanguínea , Traqueia/efeitos dos fármacos
12.
Neuroscience ; 119(4): 1113-45, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12831868

RESUMO

As melanin-concentrating hormone (MCH) neurons express the neurokinin 3 receptor (NK3) in the rat diencephalon, their innervation by tachykininergic fibers, the origin of this innervation and the effect of a NK3 agonist on MCH mRNA expression were researched. The obtained results show that the tachykininergic system develops complex relationships with MCH neurons. Overall, MCH cell bodies appeared targeted by both NKB- and SP-inputs. These afferents have multiple hypothalamic and extra-hypothalamic origins, but a local (intra-lateral hypothalamic area) origin from small interneurons was suspected as well. MCH cell bodies do not express NK1, but around 2.7% of the MCH neurons contained SP after colchicine injection. Senktide, a NK3 agonist, produced an increase of the MCH mRNA expression in cultured hypothalamic slices. This effect was reversed by two NK3 antagonists. Tachykinins enhance MCH mRNA expression, and, thus, may modulate the effect of MCH in functions such as feeding and reproductive behaviors in which this peptide has been experimentally involved.


Assuntos
Hormônios Hipotalâmicos/metabolismo , Hipotálamo/metabolismo , Melaninas/metabolismo , Vias Neurais/metabolismo , Neurônios/metabolismo , Hormônios Hipofisários/metabolismo , Receptores da Neurocinina-3/genética , Substância P/análogos & derivados , Taquicininas/metabolismo , Animais , Encéfalo/citologia , Encéfalo/metabolismo , Colchicina/metabolismo , Comportamento Alimentar/fisiologia , Hipotálamo/citologia , Interneurônios/citologia , Interneurônios/metabolismo , Masculino , Vias Neurais/citologia , Neurocinina B/agonistas , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Antagonistas dos Receptores de Neurocinina-1 , Neurônios/citologia , Técnicas de Cultura de Órgãos , Fragmentos de Peptídeos/farmacologia , Piperidinas/farmacologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores da Neurocinina-1/agonistas , Receptores da Neurocinina-1/genética , Receptores da Neurocinina-3/agonistas , Receptores da Neurocinina-3/antagonistas & inibidores , Comportamento Sexual/fisiologia , Substância P/metabolismo , Substância P/farmacologia
13.
J Biol Chem ; 276(1): 495-504, 2001 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-11013243

RESUMO

Peptoid antagonists are increasingly being described for G protein-coupled receptors; however, little is known about the molecular basis of their binding. Recently, the peptoid PD168368 was found to be a potent selective neuromedin B receptor (NMBR) antagonist. To investigate the molecular basis for its selectivity for the NMBR over the closely related receptor for gastrin-releasing peptide (GRPR), we used a chimeric receptor approach and a site-directed mutagenesis approach. Mutated receptors were transiently expressed in Balb 3T3. The extracellular domains of the NMBR were not important for the selectivity of PD168368. However, substitution of the 5th upper transmembrane domain (uTM5) of the NMBR by the comparable GRPR domains decreased the affinity 16-fold. When the reverse study was performed by substituting the uTM5 of NMBR into the GRPR, a 9-fold increase in affinity occurred. Each of the 4 amino acids that differed between NMBR and GRPR in the uTM5 region were exchanged, but only the substitution of Phe(220) for Tyr in the NMBR caused a decrease in affinity. When the reverse study was performed to attempt to demonstrate a gain of affinity in the GRPR, the substitution of Tyr(219) for Phe caused an increase in affinity. These results suggest that the hydroxyl group of Tyr(220) in uTM5 of NMBR plays a critical role for high selectivity of PD168368 for NMBR over GRPR. Receptor and ligand modeling suggests that the hydroxyl of the Tyr(220) interacts with nitrophenyl group of PD168368 likely primarily by hydrogen bonding. This result shows the selectivity of the peptoid PD168368, similar to that reported for numerous non-peptide analogues with other G protein-coupled receptors, is primarily dependent on interaction with transmembrane amino acids.


Assuntos
Indóis/farmacologia , Peptídeos/farmacologia , Piridinas/farmacologia , Receptores da Bombesina/antagonistas & inibidores , Receptores da Bombesina/metabolismo , Tirosina/metabolismo , Células 3T3 , Sequência de Aminoácidos , Substituição de Aminoácidos/genética , Animais , Sítios de Ligação , Indóis/química , Camundongos , Modelos Moleculares , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida/genética , Neurocinina B/análogos & derivados , Neurocinina B/antagonistas & inibidores , Neurocinina B/química , Neurocinina B/metabolismo , Peptídeos/química , Peptoides , Mutação Puntual/genética , Ligação Proteica , Conformação Proteica , Estrutura Terciária de Proteína , Piridinas/química , Receptores da Bombesina/química , Receptores da Bombesina/genética , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Especificidade por Substrato , Transfecção , Tirosina/genética
14.
Eur Respir J ; 9(9): 1847-51, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8880101

RESUMO

The mammalian respiratory tract is densely innervated by sensory and autonomic fibres. Subsets of the nerves contain bioactive regulatory peptides, such as substance P, calcitonin gene-related peptide (CGRP), and neurokinins. The sensory nervous system responds to inhaled irritants, resulting in a release of neuropeptides and, thus, a decrease in the peptide immunoreactivity of the fibres. We examined the effects of inhaled nitrogen dioxide (NO2), a well-known indoor and outdoor air pollutant, on pulmonary sensory neuropeptides. Guinea-pigs were exposed for 4 h to 18 parts per million (ppm) NO2 or to air (n = 5 each). At the end of the exposure, they were killed with urethane and their lungs were fixed in 1% paraformaldehyde in phosphate-buffered saline. Cryostat sections were stained with antisera to an anatomical nerve marker, protein gene product (PGP) 9.5, and to CGRP and tachykinins, utilizing the avidin-biotinylated peroxidase method. In the noncartilaginous airways (diameter < 250 microns) of NO2-exposed animals, less tachykinin- and CGRP-immunoreactive nerve fibres were found compared with controls. No change was seen in the total nerve fibre distribution (PGP 9.5). It is concluded that the peptidergic nerves of guinea-pig peripheral airways are a sensitive indicator of exposure to nitrogen dioxide.


Assuntos
Peptídeo Relacionado com Gene de Calcitonina/antagonistas & inibidores , Pulmão/efeitos dos fármacos , Dióxido de Nitrogênio/farmacologia , Oxidantes Fotoquímicos/farmacologia , Taquicininas/antagonistas & inibidores , Administração por Inalação , Poluentes Atmosféricos/farmacologia , Animais , Sistema Nervoso Autônomo/efeitos dos fármacos , Peptídeo Relacionado com Gene de Calcitonina/análise , Exposição Ambiental , Cobaias , Técnicas Imunoenzimáticas , Irritantes/farmacologia , Pulmão/inervação , Pulmão/patologia , Masculino , Fibras Nervosas/efeitos dos fármacos , Fibras Nervosas/ultraestrutura , Proteínas do Tecido Nervoso/análise , Neurocinina A/análise , Neurocinina A/antagonistas & inibidores , Neurocinina B/análise , Neurocinina B/antagonistas & inibidores , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/ultraestrutura , Dióxido de Nitrogênio/administração & dosagem , Oxidantes Fotoquímicos/administração & dosagem , Substância P/análise , Substância P/antagonistas & inibidores , Taquicininas/análise , Tioléster Hidrolases/análise , Ubiquitina Tiolesterase
15.
Eur J Pharmacol ; 306(1-3): 307-14, 1996 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-8813645

RESUMO

We examined the effect of two des-Met-bombesin analogues, [(CH3)2CHCO-His-Trp-Ala-Val-D-Ala-His-Leu-NHCH3] (ICI 216140) and [D-Phe6,des-Met14]bombesin(6-14) ethylamide (DPDM-bombesin ethylamide), on neuromedin B-induced Ca2+ and [3H]arachidonate release in BALB 3T3 cells transfected with human neuromedin B receptors. ICI 216140 and DPDM-bombesin ethylamide both stimulated Ca2+ mobilisation in a concentration-dependent manner but were less potent and efficacious than neuromedin B. BIM 23042 [D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2], a selective neuromedin B antagonist and [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a broad-spectrum peptide receptor antagonist inhibited neuromedin B-, ICI 216140 and DPDM-bombesin ethylamide-induced Ca2+ release. Pretreatment of cells with either des-Met-bombesin analogue attenuated neuromedin B-induced Ca2+ elevations, suggesting similar agonist-sensitive Ca2+ pools. The pharmacological profiles revealed from the [3H]arachidonate assay were similar, although ICI 216140 was less potent and efficacious than DPDM-bombesin ethylamide. The data suggest that ICI 216140 and DPDM-bombesin ethylamide behave as agonists at the neuromedin B receptor, perhaps as a consequence of neuromedin B receptor overexpression.


Assuntos
Ácido Araquidônico/metabolismo , Bombesina/análogos & derivados , Cálcio/metabolismo , Neurocinina B/análogos & derivados , Receptores da Bombesina/fisiologia , Somatostatina/análogos & derivados , Células 3T3/efeitos dos fármacos , Animais , Bombesina/farmacologia , Bombesina/fisiologia , Bovinos , Relação Dose-Resposta a Droga , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Neurocinina B/antagonistas & inibidores , Neurocinina B/farmacologia , Oligopeptídeos/farmacologia , Receptores da Bombesina/agonistas , Transfecção
16.
Arzneimittelforschung ; 45(11): 1194-7, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8929238

RESUMO

The effect of FK224 (N-(N2-[N-¿N-(N-2,3-didehydro-N-methyl-N-[N-3- (2-pentylphenyl)-propionyl¿-L-threonyl]tyrosyl-L-leucynyl)-D -phenylalanyl¿-L-allothreonyl]-L-asparaginyl)-L-serine-v-lacto ne, CAS 125787-94-2) on isometric contraction of canine tracheal smooth muscle in situ was studied. Contraction was induced by administration of substance P, neurokinin A, and neurokinin B intra-arterially into the tracheal circulation in five mongrel dogs. FK224 inhibited substance P- and neurokinin A-induced contraction in a dose-dependent manner, but it did not inhibit neurokinin B-induced contraction significantly. These data suggest that FK224 is a dual antagonist of both neurokinin 1 and neurokinin 2 receptors, with a similar potency in in vivo experiments.


Assuntos
Músculo Liso/efeitos dos fármacos , Antagonistas dos Receptores de Neurocinina-1 , Peptídeos Cíclicos/farmacologia , Receptores da Neurocinina-2/antagonistas & inibidores , Sistema Respiratório/efeitos dos fármacos , Animais , Cães , Feminino , Técnicas In Vitro , Contração Isométrica/efeitos dos fármacos , Masculino , Neurocinina A/antagonistas & inibidores , Neurocinina A/farmacologia , Neurocinina B/antagonistas & inibidores , Neurocinina B/farmacologia , Substância P/antagonistas & inibidores , Substância P/farmacologia , Traqueia/efeitos dos fármacos
17.
J Urol ; 154(1): 257-61, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7539864

RESUMO

When instilled intravesically in normal, unanesthetized rats, neurokinin A (NKA), but not substance P (SP) and neurokinin B (NKB), stimulated micturition. The effect of NKA was inhibited by the NK2 receptor selective antagonists SR 48,968 and MEN 10,627, but not by the NK1 receptor selective antagonist RP 67,580, suggesting that the effect was mediated by stimulation of NK2 receptors. Given intra-arterially near the bladder, NKA produced an increase in basal intravesical pressure before initiating micturition, indicating that the tachykinin had a direct contractant effect on the detrusor smooth muscle. Such a contractile effect was not observed when NKA was given intravesically. The effect of intra-arterial NKA could not be blocked by the NK1 receptor selective antagonist SR 140,333 or the NK2 receptor selective antagonist SR 48,968, but by their combination. Also intra-arterial NKB stimulated micturition, but was less potent than NKA. Intra-arterial SP had only weak stimulating effects. The results suggest that intravesically administered NKA can initiate micturition in the normal rat by stimulation of superficially located NK2 receptors in the urothelium. Intra-arterially administered NKA caused bladder hyperactivity via stimulation of both NK1 and NK2 receptors.


Assuntos
Neurocinina A/farmacologia , Neurocinina B/farmacologia , Substância P/farmacologia , Bexiga Urinária/efeitos dos fármacos , Administração Intravesical , Animais , Benzamidas/administração & dosagem , Benzamidas/farmacologia , Feminino , Indóis/administração & dosagem , Indóis/farmacologia , Injeções Intra-Arteriais , Isoindóis , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Neurocinina A/administração & dosagem , Neurocinina A/antagonistas & inibidores , Neurocinina B/administração & dosagem , Neurocinina B/antagonistas & inibidores , Antagonistas dos Receptores de Neurocinina-1 , Peptídeos Cíclicos/administração & dosagem , Peptídeos Cíclicos/farmacologia , Piperidinas/administração & dosagem , Piperidinas/farmacologia , Quinuclidinas/administração & dosagem , Quinuclidinas/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores da Neurocinina-2/antagonistas & inibidores , Substância P/administração & dosagem , Substância P/antagonistas & inibidores , Micção/efeitos dos fármacos
19.
Life Sci ; 56(1): PL27-32, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7830490

RESUMO

SR 142801 is the first potent and selective non-peptide antagonist of the tachykinin NK3 receptor. It inhibited [MePhe7]NKB binding to its receptor from various species, including humans. SR 142801 was a competitive antagonist of [MePhe7]NKB-mediated contractions of guinea-pig ileum and inhibited the acetylcholine release following the activation of the guinea-pig ileum tachykinin NK3 receptor. In vivo, SR 142801 potently inhibited the turning behaviour induced by intrastriatal injection of senktide in gerbils, and appears as a powerful tool for investigation of the physiological and pathological role of NKB and its NK3 receptor.


Assuntos
Piperidinas/farmacologia , Receptores da Neurocinina-3/antagonistas & inibidores , Animais , Comportamento Animal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Gerbillinae , Cobaias , Técnicas In Vitro , Neurocinina B/análogos & derivados , Neurocinina B/antagonistas & inibidores , Neurocinina B/metabolismo , Ratos , Vasoconstrição/efeitos dos fármacos
20.
Life Sci ; 57(3): 283-9, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7541102

RESUMO

Neurokinin A and B are present in neurons situated in lung and NK-1 receptors have been described on tracheal submucosal gland cells. In the present study we compared the ability of substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) to stimulate airway mucus secretion. Furthermore, we characterized the interaction of NKA and NKB with galanin and somatostatin. The rank order of the tachykinins to stimulate airway mucus secretion was SP > NKA > NKB suggesting that NK-1 receptors mediate these effects(EC50:SP: 50 nmol/l, NKA: 200 nmol/l, NKB: 400 nmol/l). Galanin and somatostatin were equally potent to inhibit NK-A and NK-B stimulated airway mucus release. These results suggest that NK-A and NK-B are potent stimulators of airway macromolecule secretion. Galanin and somatostatin potently inhibit these actions of the tachykinins. Therefore, airway mucus secretion is controlled by a complex network of several different mediators.


Assuntos
Neurocinina A/antagonistas & inibidores , Neurocinina B/antagonistas & inibidores , Peptídeos/farmacologia , Somatostatina/farmacologia , Traqueia/metabolismo , Animais , Galanina , Masculino , Muco/metabolismo , Neurocinina A/farmacologia , Neurocinina B/farmacologia , Neuropeptídeos/farmacologia , Ratos , Ratos Sprague-Dawley , Traqueia/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...